Trailing Twelve Months Sales Growth: Guardian Pharmacy Corp (GRDN)

The TTM year-over-year sales growth percentage helps assess the impact of government price regulations and logistical disruptions on Guardian Pharmacy Services (GRDN). High integration into clinics allows the company to index tariffs above inflation, while medication delivery for chronically ill patients guarantees a stable sales cycle. The value 4.80 is recorded as the baseline value, visualizing the smoothness of fundamental shifts in the company's revenue dynamics.
Summary analytical data breakdowns for Guardian Pharmacy Services, Inc. (GRDN)

The local supply model of Guardian Pharmacy Services (GRDN) makes the TTM year-over-year revenue growth chart a key indicator of resilience against import substance shortages. By comparing trailing 12-month revenues with the same period last year, this metric reveals the actual expansion trend, allowing investors to promptly identify operational deceleration or asset valuation overheating.